The efficacy of home warm moist compress and blephasteam in the treatment of meibomian gland dysfunction in patient using glaucoma medications: a randomized controlled trial

Status

Unknown

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20231116003

Enrollment

Registered

2023-11-16

Start date

2023-11-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy of warm compress with Pottery hot pack vs Blephasteam MGD Warm compression Blephastream

Interventions

Warm compression group with Pottery hot pack 2 times/day with standard lid hygiene everyday,Warm compression group with Blephasteam 1time with standard lid hygiene everyday

Active Comparator Device,Active Comparator Device

Warm compression group with Pottery hot pack,Blephasteam

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: MGD patients stage 2 and 3 with using glaucoma medication more than 1 year

Exclusion criteria

Exclusion criteria: Patient using contact les Onderwent ocular surgury Using antibiotic medication DM Abnormal sensation psoriasis rosacea Sjogrens syndrome Total Cholesteral more than 200

Design outcomes

Primary

Measure	Time frame
meibomian gland score 1 month meibum quality and expressibility	—

Secondary

Measure	Time frame
the Ocular Surface Disease Index (OSDI) score 1 month OSDI ,Schirmer test score 1 month Schirmer test score, TBUT 1 month seconds,corneal staining score 1 month Oxford corneal staining score,meibography score 1 month meibography score	—

Countries

Thailand

Contacts

Public ContactSiri Kowittayanon

Chiang Mai university

siripkw@gmail.com0875748308

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026